Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Trial of Hypofractionated Pre-Operative Radiation Therapy for Localized, Resectable Soft Tissue Sarcoma of the Extremity or Superficial Trunk (HYPORT-STS)

NCT03819985 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03819985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03819985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Trial of Hypofractionated Pre-Operative Radiation Therapy for Localized, Resectable Soft Tissue Sarcoma of the Extremity or Superficial Trunk (HYPORT-STS)
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 17, 2018
Completion date
August 31, 2027
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resectable soft tissue sarcoma, stage i soft tissue sarcoma of the trunk and extremities ajcc v8, stage ia soft tissue sarcoma of the trunk and extremities ajcc v8, stage ib soft tissue sarcoma of the trunk and extremities ajcc v8, stage ii soft tissue sarcoma of the trunk and extremities ajcc v8, stage iii soft tissue sarcoma of the trunk and extremities ajcc v8, stage iiia soft tissue sarcoma of the trunk and extremities ajcc v8, stage iiib soft tissue sarcoma of the trunk and extremities ajcc v8